Litigation Details for Supernus Pharmaceuticals, Inc. v. Ajanta Pharma Limited (D. Del. 2022)
✉ Email this page to a colleague
Supernus Pharmaceuticals, Inc. v. Ajanta Pharma Limited (D. Del. 2022)
Docket | ⤷ Sign Up | Date Filed | 2022-10-28 |
Court | District Court, D. Delaware | Date Terminated | 2024-01-18 |
Cause | 35:1 Patent Infringement | Assigned To | Gregory B. Williams |
Jury Demand | None | Referred To | |
Patents | 10,220,042; 7,722,898; 7,910,131; 8,617,600; 8,821,930; 9,119,791; 9,351,975; 9,370,525 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Supernus Pharmaceuticals, Inc. v. Ajanta Pharma Limited
Details for Supernus Pharmaceuticals, Inc. v. Ajanta Pharma Limited (D. Del. 2022)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2022-10-28 | 1 | Complaint | the ’278 patent”), United States Patent No. 10,220,042 (“the ’042 patent”), United States Patent No. 11,166,960…’898 patent, the ’131 patent, the ’600 patent, the ’930 patent, the ’791 patent, the ’975 patent, the…the ’131 patent”), United States Patent No. 8,617,600 (“the ’600 patent”), United States Patent No. 8,821,930…the ’930 patent”), United States Patent No. 9,119,791 (“the ’791 patent”), United States Patent No. 9,351,975…the ’975 patent”), United States Patent No. 9,370,525 (“the ’525 patent”), United States Patent No. 9, | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |